Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States
- PMID: 36883582
- PMCID: PMC10249984
- DOI: 10.1093/cid/ciad135
Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States
Conflict of interest statement
Potential conflicts of interest. K. W. G. reports research grants from Summit, Acurx, Paratek Pharmaceuticals, and Seres Health (paid to their institution). All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.Clin Infect Dis. 2023 Mar 4;76(5):890-896. doi: 10.1093/cid/ciac817. Clin Infect Dis. 2023. PMID: 36208202 Free PMC article.
References
-
- Olaitan AO, Dureja C, Youngblom MA, et al. . Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. bioRxiv, 2022, preprint: not peer reviewed. September 26, 2022. https://doi.org/10.1101/2022.09.23.509282. - PMC - PubMed